Long-term management of the renal transplant recipient: Optimizing the relationship between the transplant center and the community nephrologist

被引:13
作者
Howard, AD [1 ]
机构
[1] Metropolitan Nephrol, Alexandria, VA 22306 USA
关键词
renal transplant; transplant center; nephrologist; long-term monitoring; immunosuppressive medication;
D O I
10.1053/ajkd.2001.28926
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rapid growth in the number of kidney transplant recipients along with improved viability of transplanted organs and increased patient survival have all led to the need for effective long-term management of these patients. The increasing numbers of transplants and the duration of posttransplant medical care can overwhelm the resources of a transplant center. These factors highlight the need for optimizing the relationship between the transplant center and the community nephrologist. There are several factors that affect the timing for transitioning patients from the transplant center to the community nephrologist and no standard timing has yet been established. Continued management of pretransplant comorbid conditions is important as are monitoring for adverse effects of failure of immunosuppressive therapy and the development of posttransplant complications. An array of testing that can be useful in monitoring these patients as well as the suggested frequency for their use are reviewed. Guidelines for the optimal interaction between the transplant center and the community nephrologist are provided to include circumstances concerning adjustment or conversion of immunosuppressive medications, evidence of allograft dysfunction, and the development of malignancy. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:S51 / S57
页数:7
相关论文
共 9 条
[1]  
Friemann S, 1999, TRANSPLANT P, V31, p41S
[2]   POSTTRANSPLANT HYPERLIPIDEMIA - THE TREATMENT DILEMMA [J].
HRICIK, DE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (05) :766-771
[3]   Hyperlipidemia in patients with chronic renal disease [J].
Kasiske, BL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S142-S156
[4]  
Kasiske BL, 2000, J AM SOC NEPHROL, V11, pS1
[5]   Effects of tacrolimus on hyperlipidemia after successful renal transplantation: A Southeastern Organ Procurement Foundation multicenter clinical study [J].
McCune, TR ;
Thacker, LR ;
Peters, TG ;
Mulloy, L ;
Rohr, MS ;
Adams, PA ;
Yium, J ;
Light, JA ;
Pruett, T ;
Gaber, AO ;
Selman, SH ;
Jonsson, J ;
Hayes, JM ;
Wright, FH ;
Armata, T ;
Blanton, J ;
Burdick, JF .
TRANSPLANTATION, 1998, 65 (01) :87-92
[6]   A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation [J].
Pirsch, JD ;
Miller, J ;
Deierhoi, MH ;
Vincenti, F ;
Filo, RS .
TRANSPLANTATION, 1997, 63 (07) :977-983
[7]  
*PUTN ASS INC, 2000, PUTN COMM NEPHR SURV
[8]  
*PUTN ASS INC, 2001, PUTN AST SURV 2001
[9]  
Wierzbicki AS, 1999, INT J CLIN PRACT, V53, P54